Therapeutic benefits of neoadjuvant and post-operative denosumab on sacral giant cell tumor: a retrospective cohort study of 30 cases.

CONCLUSION: Neoadjuvant therapy with denosumab can significantly relieve the symptoms and neurologic deficits. PMID: 29745092 [PubMed - in process]
Source: Journal of B.U.ON. - Category: Cancer & Oncology Tags: J BUON Source Type: research